Behavioural Pharmacology

 

An International Forum in which
Behaviour and Pharmacology receive equal attention

 

For more detailed instruction for authors and information about subscription please visit the publisher web site dedicated to Behavioural Pharmacology:

 

topleft.gif (2315 Byte)
logobo.gif (673 Byte)

 

Editors

EDITOR

Paul Willner

Department of Psychology
University of Wales, Swansea
Singleton Park
Swansea SA2 8PP
UK

Tel: (+44) 1792 295844
Fax: (+44) 1792 295679

ASSOCIATE EDITORS

Jack Bergman

Harvard Medical School 
New England Regional Primate Res. Ctr,
Behav. Biol. Div.
1 Pine Hill Drive, PO Box 9120
Southborough, MA 01772-9102
U.S.A.

Tel: (+1) 508 624-8036
Fax: (+1) 508 624-8190


 

 

David Sanger

Sanofi-Synthelabo Recherche (LERS)
31 avenue PV Couturier
F-92220 Bagneux cedex
France

Tel: (+33) 1 45 36 24 86
Fax: (+33) 1 45 36 20 70

AIMS AND SCOPE

Behavioural Pharmacology accepts original Research Reports in diverse areas ranging from ethopharmacology to the pharmacology of schedule-controlled operant behaviour, provided that their primary focus is behavioural. Suitable topics include drug, chemical and hormonal effects on behaviour, the neurochemical mechanisms underlying behaviour, and behavioural methods for the study of drug action. Both animal and human studies are welcome; however, studies reporting neurochemical data should have a predominantly behavioural focus, and human ;studies should not consist exclusively of clinical trials or case reports. All papers will be refereed. Preference is given to studies that demonstrate and develop the potential of behavioural methods, and to papers reporting findings of direct relevance to clinical problems. Papers making a ,significant theoretical contribution are particularly welcome and, where possible and merited, space is made available for authors to explore fully the theoretical implications of their findings,. Reviews of an area of the literature or at an appropriate stage in the development of an author's own work are welcome. Commentaries in areas of current interest are also considered for publication, as are Reviews and Commentaries in areas outside behavioural pharmacology but of importance and interest to behavioural pharmacologists.

 

Behavioural Pharmacology
Instruction for Authors

 


Behavioural Pharmacology will consider for publication papers in the following categories:

  • Original research reports
  • Short reports
  • Reviews
  • Commentaries

Short Reports should be of no more than 1500 words and two tables of figures. Please contact one of the editors to discuss the suitability of topics for REVIEW-up to 7500 words, COMMENTARY-up to 2500 words, or other material falling outside the usual categories.

Submission of Manuscripts

Manuscripts can be easily submitted online with Editorial Manager. This automated, web-based tool simplifies the manuscript submission and review processes and enables users to electronically submit, review and track manuscripts and artwork online in a few easy steps. Contributors are invited to start using the system today at

https://www.editorialmanager.com/bpharm/

 

Conflict of Interest

Authors are expected to disclose any commercial or other associations that might pose a conflict of interest in connection with the submitted article. All funding sources supporting the work, and institutional or corporate affiliations of the authors, should be acknowledged on the title page. Articles are considered for publication on the understanding that neither the article nor its essential substance has been or will be published elsewhere before appearing in Behavioural Pharmacology. Abstracts and press reports published in connection with scientific meetings are not considered to be publications.

Permissions

Materials copies from other sources must be accompanied by a written statement from both author and publisher giving permission to Behavioural Pharmacology for reproduction. Obtain permission in writing from at least one author of papers still in press, of unpublished data, and of personal communications. It is the author's responsibility to ensure that permissions are obtained.

Arrangement of Manuscripts

Preface each paper with a suitable title, the author(s) name(s), and the full address of the institution in which the work was carried out (please identify the author for proofs-giving telephone and tax numbers-for correspondence and reprint requests), an abstract of no more than 200 words, and up to eight keywords. Research reports should give an appropriate introduction, a single methods section (with the methodology of all experiments reports), results, and discussion. Either British or American spellings are acceptable, but please be consistent. Authors should express measurements in SI units, although they may include older conventional units in parentheses if they wish. Except for units of measurement, abbreviations should be spelt out on first use, and should be standard. Drug names should be generic, although authors may add brand names in parentheses if they wish.

Illustrations should be likely numbered on the back in pencil, with orientation and your name. We prefer glossy photographs or professionally prepared line drawings; any lettering and symbols must be large enough to stand reduction in size-publication could be delayed if lettering or symbol are too small for half tones send unmounted glossy photographs with explanatory legends on a separate sheet of paper. Please send one set of photographs and attach a set of photocopies to each copy of the manuscript. The cost of reproducing colour illustrations is charged to the authors. Please contact the publishers for an estimate of this cost.

Tables should bear roman numerals and be typed on separate sheets of paper. Each table requires a title, but no legend; identify footnotes by superscripts.

References follow the Harvard system. In the text give the author(s) name and, in parentheses, the date of the paper/book being cited. Differentiate between papers by the same author in the same year by a, h, c etc., immediately after the date. Where there are three more authors use et al. in the text and a, h, c to resolve ambiguities. All works cited must be listed at the end of the paper, ordered alphabetically by first author's name. For each author, list single author works, next joint authored work in alphabetical order, last multiauthored works in chronological order. Each reference should give the names an initials of all authors the year of publication, the title of the paper, the name of the journal or book (Index Medicus abbreviations for journal names should be used; book title should be provided in full), the volume or edition, the first and last page, and, for books, the publisher and town of publication. For example:

 

Oglesby MW, Shippenberg TS, Herz A (1988). Tolerance and cross-tolerance to the discriminative stimulus properties of fentanyl and morphine. J Pharmacol Exp Ther 245:17-23.

Sanger DJ (1986). Drug taking as adjunctive behaviour In: Behavioural analysis of drug dependence Goldberg R, Stolerman IP (editors). New York: Academic Press. pp. 123-160.

Thompson T, Pickens R, Meish R (Eds) (1970). Readings in behavioural pharmacology. New York: Appleton-Century-Crofts.

Willner P (1984a). The validity of animal models of depression. Psychopharmacology 83:1-16.

 

Proofs, Reprints and Copyright

Authors will normally be sent page proofs by tax where available. Such corrections as are necessary should be listed in the form of a table with the location of the correction in the left~hand column and the correction required in the right-hand column. The table should be taxed to the publishers within three days of proof receipt. Alterations, other than essential corrections to the text of the paper, should not be made at this stage; the cost of such alterations may be passed on to the author.

A form for ordering reprints will be supplied with the proofs and should be returned direct to the publisher. Manuscripts are accepted for publication on the understanding that exclusive copyright is assigned to the publishers. However, this does not limit the freedom of the author(s) to use material in the papers in any other published works.

 

Ethical Policy

Studies using human subjects should include a statement within the manuscript that subjects provided informed consent for their participation and that the study was approved by a local ethics commitee.

Studies using animal subjects must conform to internationally accepted standards of animal welfare, and authors should include an appropriate statement to that effect, either within the manuscript, or in their covering letter. Every effort should be made to minimize the number of animals used.

The editors will welcome the submission of work in any area of behavioural pharmacology. However, studies that subject animals to pain or stress require special consideration and three principles will be used to judge the ethics of such work. First, experiments of this kind will be required to reach a higher threshold of scientific quality in order to he publishable. Second, the utility of the study will be addressed, in terms of the balance between the distress inflicted and the likelihood of benefit. Third, it must be demonstrated that the objectives of the experiment could not have been achieved by the use of less stressful procedures; the fact that a particular procedure has been used in previously published work will not in itself suffice. The editors believe that behavioural pharmacologists apply strict ethical criteria to their work, and will have no difficulty in meeting these requirements. 

 

For more info about subscription visit the publisher web site:


topleft.gif (2315 Byte)
logobo.gif (673 Byte)